Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Rawnoc who wrote (3211)	12/9/2014 1:30:35 AM
From: drkaz	Read Replies (1) \| Respond to of 12873

As I said on iHub,..... whatever,..... keep on reaching if it floats your boat,...... Welcome - btw - to a moderated zone you don't get to manipulate.

To: Rawnoc who wrote (3211)	12/9/2014 1:43:17 AM
From: Puffer1	Read Replies (1) \| Respond to of 12873

Funny how you can't seem to own your previous comments -- https://www.siliconinvestor.com/nfvda/boards/read_msg.aspx?message_id=97400204 Rawnoc Member Level Monday, 02/17/14 02:30:30 PM Re: robi-1-kenobi post# 80893 Post # of104985 "Thinking we'll be under a buck in a couple of months then maybe another reverse split." "What bullshit. Got a link to back up this make-believe fantasy?" LInk provided. Can't delete? Damn. Something tells me you won't fare too well on a level playing field....

To: Rawnoc who wrote (3211)	12/9/2014 1:21:39 PM
From: Puffer1	Read Replies (1) \| Respond to of 12873

NNVC hired a specialist consulting group to put together and submit the orphan application. I guess they are a fruad too? This just gets ridiculous... "NanoViricides, Inc. (OTC BB: NNVC) (the "Company") announced today that the European associates of the consulting firm Cote´ Orphan Consulting, on behalf of NanoViricides, have submitted an Orphan Drug Application to the European Medicines Agency (EMA) for DengueCide™, a drug candidate for the treatment of dengue and dengue hemorrhagic fever."